Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.
Jan. 8, 2025 — Research demonstrates that AI can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC), to enhance clinical decision making by ...
Venoplasty alone for CAS does not provide a durable solution due to the frequent reinterventions that are required. Bare-metal stent (BMS) placement has been described with variable results. In their ...